Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1997 Feb;73(856):65–68. doi: 10.1136/pgmj.73.856.65

Neutrophilic dermatoses: pyoderma gangrenosum and Sweet's syndrome.

J T Lear 1, M T Atherton 1, J P Byrne 1
PMCID: PMC2431222  PMID: 9122099

Abstract

Pyoderma gangrenosum and Sweet's syndrome are classified as neutrophilic dermatoses as they exhibit intense dermal inflammatory infiltrates composed of neutrophils with little evidence of a primary vasculitis. They share several characteristics and respond to immunosuppressives. Aetiology is felt to represent a manifestation of altered immunologic reactivity. Patients with both conditions concurrently have been described. Diagnosis is based on clinical and histopathological findings. However, clinically the typical forms of the two conditions are quite distinct: pyoderma showing cutaneous ulceration with a purple undermined border and Sweet's syndrome having tender, erythematous, nonulcerated plaques and nodules. Approximately 50% of cases of pyoderma are associated with a specific systemic disorder. These include inflammatory bowel disease, rheumatoid arthritis, non-Hodgkin's lymphoma and myeloproliferative disorders. Many associations with Sweet's syndrome have been described, including acute myeloid leukaemia, myeloma and adenocarcinomas, and haematological malignancy. There is overlap between the two conditions with lesions categorised as Sweet's syndrome being clinically more characteristic of atypical pyoderma and vice versa. We believe that pyoderma and Sweet's syndrome represent a continuum of spectrum of disease. The reason for the clinical differences between the conditions is unclear and merits further investigation but may be explained by varying levels of intensity and extent of the inflammatory process. This review will describe the pathogenesis, clinical features, diagnosis, associations and treatment of the two conditions.

Full text

PDF
65

Images in this article

66Figure 1
on p.66
67Figure 2
on p.67

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aram H. Acute febrile neutrophilic dermatosis (Sweet's syndrome). Response to dapsone. Arch Dermatol. 1984 Feb;120(2):245–247. [PubMed] [Google Scholar]
  2. Berth-Jones J., Hutchinson P. E. Sweet's syndrome and malignancy: a case associated with multiple myeloma and review of the literature. Br J Dermatol. 1989 Jul;121(1):123–127. doi: 10.1111/j.1365-2133.1989.tb01408.x. [DOI] [PubMed] [Google Scholar]
  3. Bourke J. F., Berth-Jones J., Graham-Brown R. A. Sweet's syndrome responding to cyclosporin. Br J Dermatol. 1992 Jul;127(1):36–38. doi: 10.1111/j.1365-2133.1992.tb14823.x. [DOI] [PubMed] [Google Scholar]
  4. Burton J. L. Sweet's syndrome, pyoderma gangrenosum and acute leukaemia. Br J Dermatol. 1980 Feb;102(2):239–239. doi: 10.1111/j.1365-2133.1980.tb05700.x. [DOI] [PubMed] [Google Scholar]
  5. Caughman W., Stern R., Haynes H. Neutrophilic dermatosis of myeloproliferative disorders. Atypical forms of pyoderma gangrenosum and Sweet's syndrome associated with myeloproliferative disorders. J Am Acad Dermatol. 1983 Nov;9(5):751–758. doi: 10.1016/s0190-9622(83)70191-x. [DOI] [PubMed] [Google Scholar]
  6. Cooper P. H., Innes D. J., Jr, Greer K. E. Acute febrile neutrophilic dermatosis (Sweet's syndrome) and myeloproliferative disorders. Cancer. 1983 Apr 15;51(8):1518–1526. doi: 10.1002/1097-0142(19830415)51:8<1518::aid-cncr2820510827>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  7. Curley R. K., Macfarlane A. W., Vickers C. F. Pyoderma gangrenosum treated with cyclosporin A. Br J Dermatol. 1985 Nov;113(5):601–604. doi: 10.1111/j.1365-2133.1985.tb02385.x. [DOI] [PubMed] [Google Scholar]
  8. Delaporte E., Gaveau D. J., Piette F. A., Bergoënd H. A. Acute febrile neutrophilic dermatosis (Sweet's syndrome). Association with rheumatoid vasculitis. Arch Dermatol. 1989 Aug;125(8):1101–1104. [PubMed] [Google Scholar]
  9. Duguid C. M., Powell F. C. Pyoderma gangrenosum. Clin Dermatol. 1993 Jan-Mar;11(1):129–133. doi: 10.1016/0738-081x(93)90109-p. [DOI] [PubMed] [Google Scholar]
  10. Gunawardena D. A., Gunawardena K. A., Ratnayaka R. M., Vasanthanathan N. S. The clinical spectrum of Sweet's syndrome (acute febrile neutrophilic dermatosis)-a report of eighteen cases. Br J Dermatol. 1975 Apr;92(4):363–373. doi: 10.1111/j.1365-2133.1975.tb03095.x. [DOI] [PubMed] [Google Scholar]
  11. Heise H. Akute febrile neutrophile Dermatose oder Erythema exsudativum multiforme. Dermatol Monatsschr. 1971 Apr;157(4):278–284. [PubMed] [Google Scholar]
  12. Heng M. C. Hyperbaric oxygen therapy for pyoderma gangrenosum. Aust N Z J Med. 1984 Oct;14(5):618–621. doi: 10.1111/j.1445-5994.1984.tb05011.x. [DOI] [PubMed] [Google Scholar]
  13. Horio T., Danno K., Okamoto H., Miyachi Y., Imamura S. Potassium iodide in erythema nodosum and other erythematous dermatoses. J Am Acad Dermatol. 1983 Jul;9(1):77–81. doi: 10.1016/s0190-9622(83)70110-6. [DOI] [PubMed] [Google Scholar]
  14. Jennings J. L. Pyoderma gangrenosum: successful treatment with intralesional steroids. J Am Acad Dermatol. 1983 Oct;9(4):575–580. doi: 10.1016/s0190-9622(83)70172-6. [DOI] [PubMed] [Google Scholar]
  15. Johnson M. L., Grimwood R. E. Leukocyte colony-stimulating factors. A review of associated neutrophilic dermatoses and vasculitides. Arch Dermatol. 1994 Jan;130(1):77–81. doi: 10.1001/archderm.130.1.77. [DOI] [PubMed] [Google Scholar]
  16. Kemmett D., Hunter J. A. Sweet's syndrome: a clinicopathologic review of twenty-nine cases. J Am Acad Dermatol. 1990 Sep;23(3 Pt 1):503–507. doi: 10.1016/0190-9622(90)70250-l. [DOI] [PubMed] [Google Scholar]
  17. Klock J. C., Oken R. L. Febrile neutrophilic dermatosis in acute myelogenous leukemia. Cancer. 1976 Feb;37(2):922–927. doi: 10.1002/1097-0142(197602)37:2<922::aid-cncr2820370245>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  18. Lazarus G. S., Goldsmith L. A., Rocklin R. E., Pinals R. S., de Buisseret J. P., David J. R. Pyoderma gangrenosum, altered delayed hypersensitivity and polyarthritis. Arch Dermatol. 1972 Jan;105(1):46–51. [PubMed] [Google Scholar]
  19. Perry H. O., Winkelmann R. K. Bullous pyoderma gangrenosum and leukemia. Arch Dermatol. 1972 Dec;106(6):901–905. [PubMed] [Google Scholar]
  20. Schmutz J. L., Bartin R. H., Thess F., Weber M., Beurey J. Pyoderma gangrenosum: thérapeutique par salazosulfapyridine. Ann Dermatol Venereol. 1987;114(6-7):869–870. [PubMed] [Google Scholar]
  21. Schröder J. M., Szperalski B., Koh C. J., Christophers E. IgA-associated inhibition of polymorphonuclear leukocyte chemotaxis in neutrophilic dermatoses. J Invest Dermatol. 1981 Dec;77(6):464–468. doi: 10.1111/1523-1747.ep12497599. [DOI] [PubMed] [Google Scholar]
  22. Whittle C. H., Beck G. A., Champion R. H. Recurrent neutrophilic dermatosis of the face--a variant of Sweet's syndrome. Br J Dermatol. 1968 Dec;80(12):806–810. doi: 10.1111/j.1365-2133.1968.tb11950.x. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES